392 related articles for article (PubMed ID: 26147747)
21. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
22. The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.
Guan D; Factor D; Liu Y; Wang Z; Kao HY
Oncogene; 2013 Aug; 32(33):3819-28. PubMed ID: 22945642
[TBL] [Abstract][Full Text] [Related]
23. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo.
Fang L; Shanqu L; Ping G; Ting H; Xi W; Ke D; Min L; Junxia W; Huizhong Z
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1079-87. PubMed ID: 22205202
[TBL] [Abstract][Full Text] [Related]
25. BARX2 expression is downregulated by CpG island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells.
Ma J; Xia LL; Yao XQ; Zheng SM; Li S; Xu LS; Sha WH; Li ZS
Oncol Rep; 2020 Jun; 43(6):1805-1818. PubMed ID: 32236603
[TBL] [Abstract][Full Text] [Related]
26. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
[TBL] [Abstract][Full Text] [Related]
27. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.
Zhang Y; Huang Z; Zhu Z; Zheng X; Liu J; Han Z; Ma X; Zhang Y
PLoS One; 2014; 9(10):e104252. PubMed ID: 25272010
[TBL] [Abstract][Full Text] [Related]
28. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
[TBL] [Abstract][Full Text] [Related]
29. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer.
Daskalos A; Oleksiewicz U; Filia A; Nikolaidis G; Xinarianos G; Gosney JR; Malliri A; Field JK; Liloglou T
Cancer; 2011 Mar; 117(5):1027-37. PubMed ID: 21351083
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
31. UHRF1 mediates cell migration and invasion of gastric cancer.
Zhang H; Song Y; Yang C; Wu X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352833
[TBL] [Abstract][Full Text] [Related]
32. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
[TBL] [Abstract][Full Text] [Related]
33. CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells.
Boukhari A; Alhosin M; Bronner C; Sagini K; Truchot C; Sick E; Schini-Kerth VB; André P; Mély Y; Mousli M; Gies JP
Anticancer Res; 2015 Jan; 35(1):149-57. PubMed ID: 25550546
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulator UHRF1 inactivates REST and growth suppressor gene expression via DNA methylation to promote axon regeneration.
Oh YM; Mahar M; Ewan EE; Leahy KM; Zhao G; Cavalli V
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12417-E12426. PubMed ID: 30530687
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
[TBL] [Abstract][Full Text] [Related]
37. Role of PCDH10 and its hypermethylation in human gastric cancer.
Li Z; Chim JC; Yang M; Ye J; Wong BC; Qiao L
Biochim Biophys Acta; 2012 Feb; 1823(2):298-305. PubMed ID: 22206871
[TBL] [Abstract][Full Text] [Related]
38. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
40. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
